OUR PROCESS

The Kay Yow Cancer Fund is a 501 (c)(3) charitable organization committed to the fight against all cancer affecting women. Our mission is to raise money for scientific research for the development of life-enhancing drugs and clinical studies; assisting the underserved; and unifying people for a common cause.

In partnership with The V Foundation for Cancer Research and its Scientific Advisory Board, the Kay Yow Cancer Fund Class A Board of Directors award grants through a highly competitive process. Each year, The V Foundation invites the 60+ NCI (National Cancer Institute)-designated cancer facilities to nominate their researchers for funding consideration. Additionally, prominent cancer centers across the country are invited to apply for funding. The Scientific Advisory Board reviews proposals and makes all funding recommendations. Each funded researcher is required to provide The V Foundation and the Kay Yow Cancer Fund with a project status report by Dec. 31 of the first year. Each year, both organizations meet with scientists to better understand the challenges and progress occurring in this field.

The Kay Yow Cancer Fund awards the following grant types: Designated Grants, Women’s Final Four Grants, Community Research Grants, and Community Assistance Grants. Grants are awarded as funding is available.

$5.63 million

$5.38 million

 

Click a basketball to see how our grants serve across the country.

$230,000

$230,000

Rex Healthcare Foundation, Raleigh, NC

SERVING THE UNDERSERVED, 2014 and 2012

Digital mammography equipment on Rex Healthcare's new mobile mammography unit

$100,000

$100,000

Tulane Cancer Center, New Orleans, LA

LUNG CANCER, 2013

Contributing to lung cancer

$100,000

$100,000

University of Texas Southwestern Simmons Comprehensive Cancer Center

BREAST CANCER, 2017

This grant specifically addresses triple negative breast cancer

$100,000

$100,000

Siteman Cancer Center at Washington University School of Medicine, St. Louis, MO

BREAST CANCER, 2009

Targeted nanoparticles optimized for breast cancer diagnosis and therapy

$100,000

$100,000

University of Texas Health Science Center at San Antonio, San Antonio, TX

BREAST CANCER, 2010

Novel therapeutic approach to overcome resistance to endocrine therapies of breast cancer

$1 million

$1 million

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD

BREAST CANCER, 2010

Facilitating potent breast tumor immunity by antibody-enhanced vaccination

$1 million

$1 million

The University of Texas MD Anderson Cancer Center, Houston, TX

OVARIAN CANCER, 2012

SPORE in ovarian cancer

$100,000

$100,000

University of Colorado Cancer Center, Denver, CO

BREAST CANCER, 2012

Prevention of postpartum, pregnancy-associated breast cancer

$100,000

$100,000

Vanderbilt-Ingram Cancer Center, Nashville, TN

OVARIAN CANCER, 2014

$100,000
$100,000

$100,000 - $100,000

Melvin and Bren Simon Cancer Center at Indiana University, Indianapolis, IN

WOMEN’S CANCER RESEARCH, 2016

Personalizing care for the aging women’s population

BREAST CANCER, 2011

Genetic variants, microRNA expression, and breast cancer

$1.25 million

$1.25 million

Moffitt Cancer Center, Tampa, FL

OVARIAN CANCER, 2015

Personalizing care for the aging women’s population

$1.25 million

$1.25 million

Moffitt Cancer Center, Tampa, FL

OVARIAN CANCER, 2015

Personalizing care for the aging women’s population

$100,000

$100,000

Oregon Health & Science University, Portland, OR

BREAST CANCER, 2014

The $100,000 grant was awarded to the Knight Cancer Institute to continue research on the potential effectiveness of non-steroidal anti-inflammatory drugs (NSAIDS), such as ibuprofen or aspirin, in the prevention of metastasis of breast cancer in young women

$1 million

$1 million

UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC

BREAST CANCER, 2014

The $1 million research grant was awarded to UNC Lineberger Comprehensive Cancer Center to conduct a Phase II, four-year controlled trial to evaluate the impact of a physical activity intervention program on biomarkers of aging and body composition among breast cancer survivors, age 65 and older, who are receiving adjuvant or neoadjuvant chemotherapy. The research project will be conducted as a national, multi-site collaboration with the Cancer and Aging Research Group, UNC Hospitals, affiliated community clinics, and the Alliance for Clinical Trials and Oncology.

Give Strength